secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2024-07-02T23:59:59+00:00
Accession:  0001213900-24-058621
Event type: other_material
Sentiment:  positive
Materiality: 0.55
Item codes: 1.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive amends OLC manufacturing deal with Shilpa, secures binding purchase order
--------------------------------------------------------------------------------

- Binding purchase order for OLC tablets; delivery by June 30, 2025.
- Additional OLC tablet orders required between Dec 31, 2025 and June 30, 2026.
- Company to provide funding to Shilpa for a new manufacturing line.
- Initial term extended to 8th anniversary of FDA approval of OLC NDA.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/0001213900-24-058621-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390024058621/ea0208854-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-058621

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer